Cesare Ruffolo, Marco Scarpa, Nicolò Bassi. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/economicsAntibodies, Monoclonal/therapeutic useAzathioprine/therapeutic useCost-Benefit AnalysisCrohn Disease/drug therapyDrug Therapy, CombinationHumansImmunosuppressive Agents/adverse effectsImmunosuppressive Agents/economicsImmunosuppressive Agents/therapeutic useInfliximabNeoplasms/chemically induced
Substances: See more » Antibodies, MonoclonalImmunosuppressive AgentsInfliximabAzathioprine
Year: 2010 PMID: 20848681 DOI: 10.1056/NEJMc1005805
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245